# Valacyclovir in Pain Management of Acute Apical Abscesses

> **NCT05266040** · PHASE2 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 60 (estimated)

## Conditions studied

- Acute Apical Abscess
- Pain, Acute

## Interventions

- **DRUG:** Valacyclovir 500 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05266040
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-25
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266040, "Valacyclovir in Pain Management of Acute Apical Abscesses". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05266040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*